Farmas USA

Latest Headlines-- FLU VACCINE
Daiichi Sankyo inks deal to market AstraZeneca's FluMist in Japan

September 3, 2015 | By Amirah Al Idrus
Just in time for flu season, AstraZeneca granted Daiichi Sankyo an exclusive license to market its FluMist Quadrivalent in Japan. The live attenuated vaccine, delivered nasally, went through Phase III trials in Japanese children, and a regulatory submission is being prepared for Japan.
FluGen reels in $12M to fund PhI of its universal flu jab

August 26, 2015 | By Eric Sagonowsky
A day after two high-profile organizations announced successful animal results for their own universal flu vaccine, Madison, WI-based FluGen announced a $12 million Series A round to fund the development of its candidate in the race.
J&J, Scripps Research Institute test 'universal' flu vaccine in mice, monkeys

August 26, 2015 | By Amirah Al Idrus
The NIAID may have posted 94% efficacy in mice for its investigational "universal" flu vaccine, but The Scripps Research Institute and partner Johnson & Johnson are hot on its heels.
OSU researchers point to vaccine-free flu protection

August 13, 2015 | By Eric Sagonowsky
Flu vaccines have grown into a multibillion-dollar business, but researchers at the Ohio State University have published findings that could one day transform the field and put a damper on those figures.
Novavax reports PhII success for quadrivalent seasonal flu vax

August 3, 2015 | By Amirah Al Idrus
Novavax is making waves in the influenza space, reporting positive Phase II results for its quadrivalent seasonal flu vaccine on Thursday.
NIAID scientists one step closer to 'universal' flu vaccine
July 23, 2015 | By Amirah Al Idrus
A vaccine against a wide range of flu viruses has long eluded scientists, but NIAID researchers have discovered what could be the foundation of a 'universal' flu vaccine.
Study: Flublok is more effective than traditional flu shot

July 2, 2015 | By Amirah Al Idrus
Protein Sciences released data showing that Flublok Quadrivalent--its follow-up to the FDA-approved trivalent Flublok--outperformed the traditional egg-based quadrivalent vaccine.
Move over, India--China can make WHO-approved vaccines, too

June 16, 2015 | By Amirah Al Idrus
China's growing vaccine industry scored again on Friday when the World Health Organization announced that it had approved a Chinese flu vaccine.
Manufacturing key to getting more effective flu jabs to market faster

FiercePharma Manufacturing | January 22, 2015
With the effectiveness of this year's influenza vaccines so low as to have made most of this year's vaccinations pointless, the industry is searching for avenues to abbreviate the 6-month development and manufacturing process to deal better with the kinds of virus mutations that came into play this year.

UPDATED: Novartis' Fluad off the hook in Italy following 19 deaths

December 1, 2014 | By Carly Helfand
After last week partially banning Novartis' Fluad, Italian officials now say tests on the flu vaccine show the product is safe.
-http://www.fiercevaccines.com/tags/flu-vaccine
-Joooe, pake que no se diga que yo hablo de Farmas, ni de Flu Vaccine

Galena Biopharma, Inc. (NASDAQ:GALE)
Shares of Galena Biopharma have been assigned an average recommendation of “Buy” from the eight research firms that are presently covering the firm, Market Beat reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and six have given a buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $4.86.

NYMX

+10% !!!

Ok, oído cocina...
Me abstendré de publicar mis movimientos y me dedicaré a leeros...
Por última vez, publico mi cartera.....

ARRY GALE IDRA THLD

ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Novavax, Inc.
File No. 0-26770 - CF#32940
______________________
Novavax, Inc. submitted an application under Rule 24b-2 requesting confidential
treatment for information it excluded from the Exhibits to a Form 8-K filed on September
8, 2015.
Based on representations by Novavax, Inc. that this information qualifies as
confidential commercial or financial information under the Freedom of Information Act,
5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly
disclose it. Accordingly, excluded information from the following exhibit(s) will not be
released to the public for the time period(s) specified:
Exhibit 10.1 through August 9, 2017

Mi no entender. Qué significa esto?
NVAX

Goldman Sachs espera que el S&P500 suba un 6%
Los expertos de la firma, además, siguen reiterando que la FED subirá los tipos de interés en la reunión que mantendrá la Reserva Federal el mes de diciembre.
En cuanto a la estrategia, los expertos de Goldman siguen siendo optimistas con respecto a la renta variable de Estados Unidos.

Leer más: http://www.estrategiasdeinversion.com/invertir-corto/analisis/goldman-sachs-espera-s-p-500-suba-6-289885#ixzz3mTxS5Gb6

Pues secundo completamente la moción! Aquí esto se está volviendo un gallinero difícil de seguir con micro farmas que en principio tienen el espacio en otro hilo pero ni caso con él. También existe el de "Otras Aventuras" para no farmas y excepto 4 gatos, la mayoría postea aquí cualquier cosa.

Lo del foro de google que comenta Ana no tengo ni idea de lo que es! Pero secundo la moción también! jaja

En fin, lo que digais, pero es una pena que no podamos aprender todos de todos un poco, ya sea con una farma mayor o con una menor, pero si lo quereis así, pues adelante....

Un saludo